RRM2 and liver cancer: We tested an RRM2 inhibitor, triapine28 and a WEE1 inhibitor MK1775 which has been shown to inhibit cell cycle via depleting RRM229, in HB cells in comparison to other standard liver cancer chemotherapies including cisplatin, gemcitabine, vincristine, and SN38, an active form of irinotecan30.